A randomized pharmacokinetic and pharmacodynamic trial of two regular human insulins demonstrates bioequivalence in type 1 diabetes and availability of biosimilar insulin may improve access to this medication.

Humulin R (recombinant human insulin) - Alzheimer's Disease Cooperative Study, Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/35441466

Apr 21, 2022